This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Campbell Soup's (CPB) Snacks Unit Stays Resilient Amid Hurdles
by Zacks Equity Research
Campbell Soup's (CPB) Snacks division, anchored by robust power brands, remains solid despite temporary pressures. The acquisition of Sovos Brands has also proven fruitful.
United Natural (UNFI) Gains on Strong E-commerce Amid Setbacks
by Zacks Equity Research
United Natural's (UNFI) performance is positively impacted by its strong presence in e-commerce. The company is actively enhancing its supply chain processes.
J.M. Smucker (SJM) & Acosta Group Strengthen Marketing Ties
by Zacks Equity Research
The J.M. Smucker Company (SJM) is expanding its collaboration with Acosta Group which will help it cater well to its retail customers and consumers.
Conagra (CAG) Q4 Earnings Top Despite Soft Consumption Trends
by Zacks Equity Research
Conagra's (CAG) fourth-quarter results reflect a continuation of the slowdown in consumption leading to soft sales. However, supply-chain productivity efforts aid gross margin expansion.
Hershey (HSY) Benefits From Robust Buyouts & Innovation
by Zacks Equity Research
Hershey (HSY) is undertaking buyouts to augment portfolio strength and boost revenues. The company is undertaking strategic pricing initiatives.
Conagra Brands (CAG) Q4 Earnings Surpass Estimates
by Zacks Equity Research
Conagra Brands (CAG) delivered earnings and revenue surprises of 8.93% and 1.13%, respectively, for the quarter ended May 2024. Do the numbers hold clues to what lies ahead for the stock?
Helen of Troy (HELE) Lags Q1 Earnings Estimates, Cuts FY25 View
by Zacks Equity Research
Helen of Troy's (HELE) fiscal first-quarter results reflect reduced sales and earnings due to lower demand for its products. Management lowered the fiscal 2025 outlook.
Colgate's (CL) Innovation & Pricing Efforts Aid: Apt to Buy?
by Zacks Equity Research
Colgate (CL) benefits from robust pricing and productivity initiatives. The company's innovation strategy also bodes well.
Tyson Foods' (TSN) Latest Deal Likely to Optimize Plant Network
by Zacks Equity Research
Tyson Foods (TSN) inks a deal to divest its Vienna, GA, poultry complex to House of Raeford Farms. This is likely to help the company optimize the plant network and enhance operations.
Clorox's (CLX) Pricing & Cost Saving on Track: Apt to Hold?
by Zacks Equity Research
Clorox (CLX) benefits from robust pricing and cost-saving initiatives. The company's IGNITE strategy also bodes well.
Nu Skin (NUS) Navigates a Tough Landscape on Growth Strategies
by Zacks Equity Research
Nu Skin (NUS) has been dealing with challenges related to customer and affiliate acquisition. However, product launches, technological advancements and strength in the Rhyz business bode well.
Keurig Dr Pepper's (KDP) Brands & Pricing Aid: Apt to Hold?
by Zacks Equity Research
Keurig Dr Pepper (KDP) gains from brand strength, significant pricing actions and a solid performance in its Refreshment Beverages segment.
COTY Benefits From Focus on Growth Pillars Amid Cost Woes
by Zacks Equity Research
COTY benefits from a focus on strategic growth pillars and strong partnerships. However, challenges from a high-cost operating environment are a concern.
Constellation Brands (STZ) Rises on Q1 Earnings Beat, Solid View
by Zacks Equity Research
Constellation Brands' (STZ) Q1 results reflect continued volume growth in the beer business and gains from improved operating margin expansion.
Foodservice Demand Aids Hormel Foods (HRL), High Costs Ail
by Zacks Equity Research
Hormel Foods (HRL) is capitalizing on the increasing demand for Foodservice products. However, rising selling, general and administrative (SG&A) expenses are a deterrent.
Mondelez (MDLZ) Navigates Hurdles Through Portfolio Strength
by Zacks Equity Research
Mondelez's (MDLZ) focus on core categories and portfolio strength place it well in a challenging and dynamic operating environment.
Altria (MO) Up 11% in 3 Months: Is There More Room for Growth?
by Zacks Equity Research
Altria (MO) is benefiting from its focus on expanding smoke-free alternatives and strong pricing power amid low cigarette volumes.
Estee Lauder (EL) on Track With Profit Recovery Amid Hurdles
by Zacks Equity Research
Estee Lauder (EL) is on track to operationalize the Profit Recovery Plan to focus on rebuilding stronger and more sustainable profitability alongside supporting sales growth.
Church & Dwight (CHD) Benefits From Robust Pricing & Brands
by Zacks Equity Research
Church & Dwight (CHD) is resorting to incremental pricing across its portfolio to counter rising costs. Also, it is capitalizing on strong consumer demand for its brands.
Inter Parfums (IPAR) Benefits from Solid Brands Amid High Cost
by Zacks Equity Research
Inter Parfums (IPAR) is benefiting from continued momentum in the fragrance market and successful product launches.
Philip Morris (PM) Gains From Smoke-Free Focus, Key Priorities
by Zacks Equity Research
Robust pricing, strength in smoke-free products and solid cost initiatives work well for Philip Morris (PM) amid elevated costs and volatile currency movements.
United Natural (UNFI) Benefits From Transformation Efforts
by Zacks Equity Research
United Natural (UNFI) embarks on a transformation journey, which includes expanding and intensifying network optimization efforts as well as optimizing cost structures.
Monster Beverage's (MNST) Strategies Seem Prudent: Apt to Hold
by Zacks Equity Research
Monster Beverage (MNST) sees strength in its energy drinks category. In addition, the company's expansion strategy bodes well.
McCormick (MKC) Q2 Earnings Top Estimates, Volumes Down
by Zacks Equity Research
McCormick's (MKC) second-quarter earnings reflect gains from strong brands and a focus on high-growth areas. However, lower volumes acted as a deterrent.
Should You Invest in the First Trust Consumer Staples AlphaDEX ETF (FXG)?
by Zacks Equity Research
Sector ETF report for FXG